| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.00093 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0005 | 1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |